News
CMND
1.630
-6.86%
-0.120
Weekly Report: what happened at CMND last week (0803-0807)?
Weekly Report · 10h ago
Weekly Buzz: MRNA, NVS, SNY Gain Approvals; EBS, LSTA Cut Jobs; TARS, BIVI Drive Deals & Data
NASDAQ · 3d ago
Psychedelic: Compass Pathways, GH Research report quarterly earnings
TipRanks · 4d ago
Clearmind Medicine reports DSMB approves advancing Phase I/II AUD study
TipRanks · 4d ago
Clearmind Medicine Signs LOI To Acquire 51% Stake In EV Wireless Charging Solutions; Stock Down
NASDAQ · 6d ago
*Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions Company for $2.5M
Dow Jones · 08/03 12:05
Weekly Report: what happened at CMND last week (0727-0731)?
Weekly Report · 08/03 09:32
Psychedelic: Clearmind reports safety findings for CMND-100
TipRanks · 07/30 14:45
Clearmind Medicine announces safety results from Part A of CMND-100 tral
TipRanks · 07/30 13:45
Clearmind Medicine Announces Safety Results From Part A Of Its Ongoing FDA-regulated Phase I/II Clinical Trial Evaluating CMND-100; All 24 Participants Enrolled Across Four Ascending-Dose Cohorts Successfully Completed Treatment
Benzinga · 07/30 12:32
Clearmind Medicine completes Part A of CMND-100 trial
TipRanks · 07/28 11:55
Clearmind Medicine Completes Treatment For All Participants In Part A Of Its Ongoing Phase I/II Clinical Trial Evaluating CMND-100 For Alcohol Use Disorder
Benzinga · 07/28 11:49
Weekly Report: what happened at CMND last week (0720-0724)?
Weekly Report · 07/27 09:34
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
TipRanks · 07/23 15:10
Clearmind files psychedelic patent application with Hong Kong Patent Office
TipRanks · 07/20 12:00
Clearmind Medicine Files Hong Kong Patent Application For Innovative Psychedelic Compounds For Treatment Of Post-Traumatic Stress Disorder
Benzinga · 07/20 11:57
Weekly Report: what happened at CMND last week (0713-0717)?
Weekly Report · 07/20 09:32
Clearmind Reports Positive Ex Vivo Data For Intranasal MEAI Drug; Stock Up
NASDAQ · 07/16 16:34
Clearmind reports positive retention results for intranasal formulation of MEAI
TipRanks · 07/16 13:35
Clearmind Medicine Announces Ex Vivo Mucoadhesion Results For Intranasal MEAI; New Formulation Demonstrated Markedly Improved Nasal Residence Characteristics Compared With Standard MEAI Solution
Benzinga · 07/16 13:32
More
Webull provides a variety of real-time CMND stock news. You can receive the latest news about Clearmind Medici through multiple platforms. This information may help you make smarter investment decisions.
About CMND
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.